Large scale validation of an early-age eye-tracking biomarker of an autism spectrum disorder subtype.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 03 2022
Historique:
received: 10 08 2021
accepted: 28 02 2022
entrez: 12 3 2022
pubmed: 13 3 2022
medline: 27 4 2022
Statut: epublish

Résumé

Few clinically validated biomarkers of ASD exist which can rapidly, accurately, and objectively identify autism during the first years of life and be used to support optimized treatment outcomes and advances in precision medicine. As such, the goal of the present study was to leverage both simple and computationally-advanced approaches to validate an eye-tracking measure of social attention preference, the GeoPref Test, among 1,863 ASD, delayed, or typical toddlers (12-48 months) referred from the community or general population via a primary care universal screening program. Toddlers participated in diagnostic and psychometric evaluations and the GeoPref Test: a 1-min movie containing side-by-side dynamic social and geometric images. Following testing, diagnosis was denoted as ASD, ASD features, LD, GDD, Other, typical sibling of ASD proband, or typical. Relative to other diagnostic groups, ASD toddlers exhibited the highest levels of visual attention towards geometric images and those with especially high fixation levels exhibited poor clinical profiles. Using the 69% fixation threshold, the GeoPref Test had 98% specificity, 17% sensitivity, 81% PPV, and 65% NPV. Sensitivity increased to 33% when saccades were included, with comparable validity across sex, ethnicity, or race. The GeoPref Test was also highly reliable up to 24 months following the initial test. Finally, fixation levels among twins concordant for ASD were significantly correlated, indicating that GeoPref Test performance may be genetically driven. As the GeoPref Test yields few false positives (~ 2%) and is equally valid across demographic categories, the current findings highlight the ability of the GeoPref Test to rapidly and accurately detect autism before the 2nd birthday in a subset of children and serve as a biomarker for a unique ASD subtype in clinical trials.

Identifiants

pubmed: 35277549
doi: 10.1038/s41598-022-08102-6
pii: 10.1038/s41598-022-08102-6
pmc: PMC8917231
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4253

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH118879
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH080134
Pays : United States
Organisme : NIMH NIH HHS
ID : P50-MH081755
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH118879
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

PLoS One. 2017 Nov 30;12(11):e0188826
pubmed: 29190703
Acta Paedopsychiatr. 1968;35(4):100-36
pubmed: 4880460
Res Dev Disabil. 2016 Jan;48:79-93
pubmed: 26547134
Nat Med. 2016 Apr;22(4):345-61
pubmed: 27050589
J Stat Softw. 2012 Mar;46(11):
pubmed: 23050260
Elife. 2019 Dec 17;8:
pubmed: 31843053
PLoS One. 2021 Jun 4;16(6):e0252795
pubmed: 34086803
Res Autism Spectr Disord. 2012 Apr;6(2):842-851
pubmed: 22639682
Transl Psychiatry. 2016 May 17;6:e808
pubmed: 27187230
J Autism Dev Disord. 2014 Mar;44(3):584-92
pubmed: 23918441
Clin Psychol Rev. 2021 Jul;87:102033
pubmed: 33962352
J Child Psychol Psychiatry. 2012 Aug;53(8):903-13
pubmed: 22428993
PLoS One. 2015 Mar 17;10(3):e0122280
pubmed: 25781170
J Comp Neurol. 1997 Oct 20;387(2):167-78
pubmed: 9336221
J Autism Dev Disord. 2020 Dec;50(12):4412-4430
pubmed: 32279223
J Autism Dev Disord. 2021 Mar;51(3):994-1006
pubmed: 33591436
JAMA Pediatr. 2021 Aug 1;175(8):827-836
pubmed: 33900383
Arch Gen Psychiatry. 2008 Aug;65(8):946-54
pubmed: 18678799
J Pediatr. 2021 Sep;236:179-188
pubmed: 33915154
Nat Genet. 2019 Mar;51(3):431-444
pubmed: 30804558
Mol Autism. 2020 Oct 19;11(1):79
pubmed: 33076994
J Neurodev Disord. 2013 Mar 27;5(1):7
pubmed: 23536992
J Child Psychol Psychiatry. 2016 Jan;57(1):93-102
pubmed: 26264996
Orphanet J Rare Dis. 2019 Nov 15;14(1):262
pubmed: 31730500
J Autism Dev Disord. 2017 Feb;47(2):506-513
pubmed: 27878742
J Neurodev Disord. 2019 Jan 21;11(1):1
pubmed: 30665413
MMWR Surveill Summ. 2014 Mar 28;63(2):1-21
pubmed: 24670961
Autism Res. 2015 Oct;8(5):620-8
pubmed: 26069030
Autism Res. 2010 Dec;3(6):293-302
pubmed: 21182206
Circulation. 2017 Feb 7;135(6):544-555
pubmed: 28153991
Pediatrics. 1975 Oct;56(4):544-9
pubmed: 1165958
Mol Autism. 2020 Apr 9;11(1):24
pubmed: 32272970
Dev Cogn Neurosci. 2018 Jan;29:30-40
pubmed: 28869201
Mol Autism. 2018 Mar 21;9:19
pubmed: 29581878
Biol Psychiatry. 2016 Apr 15;79(8):657-66
pubmed: 25981170
Am J Psychiatry. 2021 Jan 1;178(1):77-86
pubmed: 33384013
JCO Precis Oncol. 2018 Mar 09;2:
pubmed: 32913985
Epidemiology. 2002 Jul;13(4):417-23
pubmed: 12094096
Front Integr Neurosci. 2020 Apr 09;14:16
pubmed: 32346363
JAMA. 2009 Jul 22;302(4):385-93
pubmed: 19622817
Nature. 2009 May 14;459(7244):257-61
pubmed: 19329996
Autism. 2020 Apr;24(3):658-669
pubmed: 31647314
Arch Gen Psychiatry. 2011 Jan;68(1):101-9
pubmed: 20819977
Brain Res. 2011 Mar 22;1380:246-54
pubmed: 21129365
Dev Cogn Neurosci. 2018 Jan;29:41-53
pubmed: 28889988
J Genet Psychol. 1979 Sep;135(1st Half):3-9
pubmed: 512642
Autism Res. 2019 May;12(5):779-793
pubmed: 30891960
Dev Psychobiol. 2011 Mar;53(2):157-65
pubmed: 20945410
J Autism Dev Disord. 2021 Apr;51(4):1353-1364
pubmed: 32691191
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Eur Child Adolesc Psychiatry. 2021 Feb;30(2):283-291
pubmed: 32215734
Nature. 2013 Dec 19;504(7480):427-31
pubmed: 24196715
Autism Res. 2008 Feb;1(1):31-42
pubmed: 19360648
Proc Natl Acad Sci U S A. 2015 Sep 29;112(39):E5434-42
pubmed: 26371313
Mol Psychiatry. 2019 Jan;24(1):88-107
pubmed: 29934544
Autism Res. 2018 Nov;11(11):1554-1566
pubmed: 30273450
MMWR Surveill Summ. 2020 Mar 27;69(4):1-12
pubmed: 32214087
Autism. 2016 Jul;20(5):628-34
pubmed: 26825959
J Autism Dev Disord. 1985 Mar;15(1):55-76
pubmed: 3980430
Front Neurosci. 2016 Dec 23;10:586
pubmed: 28066169
J Pediatr. 2011 Sep;159(3):458-465.e1-6
pubmed: 21524759
JAMA Netw Open. 2021 Mar 1;4(3):e210771
pubmed: 33666658
Hum Brain Mapp. 2019 Feb 1;40(2):628-637
pubmed: 30251763
Transl Psychiatry. 2020 May 12;10(1):142
pubmed: 32398642
J Am Acad Child Adolesc Psychiatry. 2018 Nov;57(11):858-866
pubmed: 30392627
Child Dev. 1965 Jun;36:454-65
pubmed: 14300865
Biol Psychiatry. 2013 Aug 1;74(3):195-203
pubmed: 23313640
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730
Sci Rep. 2021 Apr 19;11(1):8461
pubmed: 33875728
Am J Public Health. 2008 Jul;98(7):1248-55
pubmed: 18511728
Neuron. 2015 Apr 22;86(2):567-77
pubmed: 25864635
Trends Neurosci. 2020 May;43(5):326-342
pubmed: 32353336
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Dev Psychopathol. 2013 May;25(2):307-20
pubmed: 23627946
Autism. 2017 Aug;21(6):772-784
pubmed: 28429618
Res Dev Disabil. 2017 Sep;68:88-94
pubmed: 28750207
Sci Rep. 2016 May 10;6:25776
pubmed: 27161545
IEEE Trans Affect Comput. 2021 Jul-Sep;12(3):722-731
pubmed: 35450132
Contemp Clin Trials Commun. 2019 Jun 14;15:100396
pubmed: 31294127
Infancy. 2021 Jul;26(4):617-634
pubmed: 33856110
Nature. 2017 Jul 20;547(7663):340-344
pubmed: 28700580
J Child Psychol Psychiatry. 2004 Oct;45(7):1235-45
pubmed: 15335344
J Autism Dev Disord. 2020 Mar;50(3):924-934
pubmed: 31811617
Autism Res. 2018 Dec;11(12):1635-1642
pubmed: 30485722
Nat Rev Neurol. 2014 Feb;10(2):74-81
pubmed: 24468882
Psychol Med. 2020 Feb;50(3):475-483
pubmed: 30829191
N Engl J Med. 1988 May 26;318(21):1349-54
pubmed: 3367935
Arch Gen Psychiatry. 2002 Sep;59(9):809-16
pubmed: 12215080
Intellect Dev Disabil. 2018 Oct;56(5):321-336
pubmed: 30273522
Infancy. 2012 Jul;17(4):355-375
pubmed: 32693486
Autism Res. 2021 Jun;14(6):1271-1283
pubmed: 33682319
J Autism Dev Disord. 2022 Mar;52(3):1120-1130
pubmed: 33871736
Autism Res. 2021 Oct;14(10):2143-2155
pubmed: 34145789

Auteurs

Teresa H Wen (TH)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA. thwen@health.ucsd.edu.

Amanda Cheng (A)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA.

Charlene Andreason (C)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA.

Javad Zahiri (J)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA.

Yaqiong Xiao (Y)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA.

Ronghui Xu (R)

Herbert Wertheim School of Public Health and Department of Mathematics, University of California, San Diego, La Jolla, CA, USA.

Bokan Bao (B)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA.
Department of Bioinformatics and Systems Biology, University of California, San Diego, La Jolla, CA, USA.

Eric Courchesne (E)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA.

Cynthia Carter Barnes (CC)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA.

Steven J Arias (SJ)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA.

Karen Pierce (K)

Autism Center of Excellence, Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Dr., La Jolla, CA, 92037, USA. kpierce@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH